ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $168,000 | +194.7% | 46,734 | +174.1% | 0.00% | – |
| Q2 2019 | $57,000 | +185.0% | 17,048 | +128.8% | 0.00% | – |
| Q1 2019 | $20,000 | -4.8% | 7,450 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -32.3% | 7,450 | 0.0% | 0.00% | – |
| Q3 2018 | $31,000 | -20.5% | 7,450 | 0.0% | 0.00% | – |
| Q2 2018 | $39,000 | -4.9% | 7,450 | 0.0% | 0.00% | – |
| Q1 2018 | $41,000 | -82.3% | 7,450 | -73.7% | 0.00% | -100.0% |
| Q4 2017 | $231,000 | -22.0% | 28,311 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $296,000 | -5.4% | 28,311 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $313,000 | +32.1% | 28,311 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $237,000 | +20.9% | 28,311 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $196,000 | +4.8% | 28,311 | -22.8% | 0.00% | 0.0% |
| Q3 2016 | $187,000 | +52.0% | 36,685 | +78.5% | 0.00% | 0.0% |
| Q2 2016 | $123,000 | +310.0% | 20,551 | +207.8% | 0.00% | – |
| Q1 2016 | $30,000 | – | 6,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |